Geri
AKADEMİK

(Liste, ünvan ve isme göre alfabetik olarak sıralanmıştır.)

Kurum İçi Görevlendirme

text
Adı Soyadı Prof.Dr. Hanefi ÖZBEK
E-Posta hozbek@medipol.edu.tr
Detay Öz Geçmiş
Medya

Ege Üniversitesi 1991 Yüzüncü Yıl Üniversitesi

Daha Önce Görev Yaptığı Yerler

Yüzüncü Yıl Üniversitesi Tıp Fakültesi, Sağlık Bakanlığı İlaç ve Eczacılık Genel Müdürlüğü (Genel Müdür Yrd), Türkiye İlaç ve Tıbbi Cihaz Kurumu (Kurum Başkan Yrd)

Araştırma Alanları

Araştırma alanları: Toksisite Karaciğeri koruyucu etki Analjezik aktivite İnflamasyon Türk Müziği Teorisi Müzik Terapi Biyoistatistik

Seçili Yayınları / Tüm Yayınları

Aydın, S., H. Özbek, Y. Yılmaz, M.K. Atilla, H. Bayraklı and H. Çetin, “Effects of sildenafil citrate, acetylcholine, and sodium nitroprusside on the relaxation of rabbit cavernosal tissue in vitro”, Urology, 58(1), 119-124 (2001).

Özbek, H., N. Güler, S. Aydın, B. Eryonucu and M. Bilge, “Sildenafil sitratın izole sıçan aortası üzerine etkileri: Karşılaştırmalı in vitro çalışma”, Anadolu Kardiyoloji Dergisi, 1: 23-26 (2001).

Durak, İ., H. Özbek, M. Karaayvaz and H.S. Öztürk, “Cisplatin induces acute renal failure by impairing antioxidant system guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity”, Drug Chem. Toxicol., 25, 1-8 (2002).

Özbek, H., S. Uğraş, H. Dülger, İ. Bayram, İ. Tuncer, G. Öztürk and A. Öztürk, “Hepatoprotective effect of Foeniculum vulgare essential oil”, Fitoterapia, 74(3): 317-319 (2003).

Özbek, H., M. Öztürk, İ. Bayram, S. Uğraş and G.S. Çitoğlu, “Hypoglycemic and hepatoprotective effects of Foeniculum vulgare Miller seed fixed oil extract in mice and rats”, East. J. Med., 8(2), 35-40 (2003).

Türkdoğan, M.K., H. Ozbek, Z. Yener, I. Tuncer, I Uygan and E. Ceylan, “The role of Urtica dioica and Nigella sativa in the prevention of Carbon tetrachloride-induced hepatotoxicity in rats”, Phytother. Res., 17, 942-946 (2003).

Özbek, H., M. Öztürk, İ. Bayram, S. Uğraş and G.S. Çitoğlu, “Hypoglycemic and hepatoprotective effects of Foeniculum vulgare Miller seed fixed oil extract in mice and rats”, East. J. Med., 8(2), 35-40 (2003).

Çelik, İ. and H. Özbek, “Effect of subchronic exposure to thiocarbamide on haematological and biochemical constituents of rats”, Fresen. Environ. Bull., 13(2), 159-163 (2004).

Özbek, H., S. Uğraş, İ. Bayram, İ. Uygan, E. Erdoğan, A. Öztürk and Z. Huyut, “Hepatoprotective effect of Foeniculum vulgare essential oil: A carbon-tetrachloride induced liver fibrosis model in rats”, Scand. J. Lab. Anim. Sci., 31(1), 9-17 (2004).

Durak, İ., H. Özbek and S. Elgün, “Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants”, Int. Immunopharmacol., 4(3), 469-473 (2004).

Özbek, H., E. Ceylan, M. Kara M, F. Özgökçe and M. Koyuncu, “Hypoglycemic efect of Rheum ribes roots in alloxan induced diabetic and normal mice”, Scand. J. Lab. Anim. Sci., 31(2), 113-115 (2004).

Özbek, H., G.S. Çitoğlu, H. Dülger, S. Uğraş and B. Sever, “Hepatoprotective and antiinflammatory activities of Ballota glandulosissima”, J. Ethnopharmacol., 95, 143-149 (2004).

Durak, I., H. Özbek, E. Devrim, N. Karagenç and I.B. Ergüder, “Effects of cholesterol supplementation on antioxidant enzyme activities in rat hepatic tissues: possible implications of hepatic paraoxonase in atherogenesis”, Nutr. Metab. Cardiovas., 14(4), 211-214 (2004).

Akdeniz, N., O. Calka, H. Ozbek and A. Metin, “Anti-inflammatory effects of tretinoin (all-trans-retinoic acid) 0.1% and adapalene 0.1% in rats”, Clin. Exp. Dermatol., 30(5), 570-572 (2005).

Özbek, H. “The anti-inflammatory activity of the Foeniculum vulgare L. essential oil and investigation of its median lethal dose in rats and mice”, Int. J. Pharmacol., 1(4), 329-331 (2005).

Özbek, H., İ. Bayram, M. Ozturk, E. Erdogan, S. Alici and İ. Uygan, “Risk of Gastrointestinal Cancer in Mice after Consuming Salted and Dried Fish in Van-Ercis Region”, Int. J. Cancer Res., 1(2), 106-108 (2005).

Özbek, H. “The anti-inflammatory activity of the Foeniculum vulgare L. essential oil and investigation of its median lethal dose in rats and mice”, Int. J. Pharmacol., 1(4), 329-331 (2005).

Özbek, H. and O. Yılmaz, “The antiinflammatory activity and median lethal dose of the Foeniculum vulgare Mill. (etheric oil)”, Recent Progress in Medicinal Plants, 12, 385-391 (2006).

Yılmaz BS, Özbek H, Çitoğlu GS, Uğraş S, Bayram İ, Erdoğan E. Analgesic and hepatotoxic effects of Ononis spinosa L. Phytother Res 2006, 20:500-503.

Yılmaz BS, Özbek H, Çitoğlu GS. Antinociceptive and anti-inflammatory activities of Ballota inaequidens. Pharmaceutical Biology 2006, 44(8): 636-641.

Özbek, H., N. Güler and B. Eryonucu, “Vasorelaxant effects of sildenafil and verapamil isolated rat aorta with and without intact endothelium”, Int. J. Pharmacol., 2(1), 142-145 (2006).

Özbek, H. and O. Yılmaz, “The antiinflammatory activity and median lethal dose of the Foeniculum vulgare Mill. (etheric oil)”, Recent Progress in Medicinal Plants, 12, 385-391 (2006).

Özbek, H., A. Taş, F. Özgökçe, N. Selçuk, Ş. Alp and S. Karagöz, “Evaluation of median lethal dose and analgesic activity of Foeniculum vulgare Miller essential oil”, Int. J. Pharmacol., 2(2), 181-183 (2006).

Özbek H, Bayram İ, Uğraş S, Cengiz N. Investigation of hepatoprotective effect of Foeniculum vulgare Fixed oil in rats. Research Journal of Medicine and Medical sciences 2006, 1(2): 72-76

Devrim, E., H. Özbek ve İ. Durak. Effects of High Cholesterol Diet and Antioxidant Vitamins Combination on Oxidant/Antioxidant Status in Heart, Kidney, Liver and Testis Tissues from Rats, J. Food Lipids 2007, 14(4): 386-395.

Özbek, H., M. Öztürk, E. Erdoğan, M. Kösem, “Are Nigella sativa and Urtica dioica Fixed Oils Effective On Carbon Tetrachloride-Induced Liver Injury Model In Rats?” Recent Progress in Medicinal Plants 2007, 19: 127-136.

Özbek, H., M. Öztürk, E. Erdoğan, M. Kösem, “Are Nigella sativa and Urtica dioica Fixed Oils Effective On Carbon Tetrachloride-Induced Liver Injury Model In Rats?” Recent Progress in Medicinal Plants 2007, 19: 127-136.

Özbek, H., M. Öztürk, F. Özgökçe, Investigation of median lethal dose (LD50) and hypoglycemic effect of Thymus fallax F. leaves essential oil. Recent Progress in Medicinal Plants, 23, Chapter 18, pp: 255-261 (2008).

Özbek, H., M. Öztürk, F. Özgökçe, Investigation of median lethal dose (LD50) and hypoglycemic effect of Thymus fallax F. leaves essential oil. Recent Progress in Medicinal Plants, 23, Chapter 18, pp: 255-261 (2008).

Tekin, M., H. Özbek, A. Him. “Investigation of Acute Toxicity, Anti-inflammatory, and Analgesic Effect of Urtica dioica L.” Pharmacologyonline, 1, 1210-1215 (2009).

Altun, M.L., H. Özbek, G.S. Çitoğlu, B.S. Yılmaz, İ. Bayram, N. Cengiz. “Hepatoprotective and hypoglycemic activities of Viburnum opulus L.” Turk J Pharm Sci, 7(1), 35-48 (2010).

Bahadır O, Saltan Çitoğlu G, Ozbek H,Dall'acqua S, Hošek J, Smejkal K. Hepatoprotectiveand TNF-? Inhibitory Activity of Zosima absinthifolia Extracts and Coumarins. Fitoterapia 2011 82(3): 454-459.

Bayram İ, Erten R, BayramY, Bulut G, Özbek H. The hepatoprotective effects of dihydromyrcenol andgeranyl formate in an experimental model of acute hepatic injury by the use ofcarbon tetrachloride. Turk F Gastroenterol, 2011; 22(6): 594-601.

Saltan Çitoğlu G, BahadırAcıkara O, Sever Yılmaz B, Ozbek H. Evaluation of analgesic,anti-inflammatory and hepatoprotective effects of lycorine from Sternbergiafisheriana (Herbert) Rupr. Fitoterapia, 2012 83(1): 81-7.

Bahadır Ö, Saltan G, ÖzbekH. Antinociceptive activity of some Scorzonera L. Species. Turk J Med Sci,2012; 42(1): 1-6.

Cengiz N,Kavak S,Güzel A,Ozbek H,Bektaş H,Him A, Erdoğan E,Balahoroğlu R.Investigation of the Hepatoprotective Effects of Sesame (Sesamum indicum L.) inCarbon Tetrachloride-Induced Liver Toxicity. J Membr Biol 2013, 246(1): 1-6.

O. Bahadır Acikara, G. Saltan Citoglu, S. Dall’Acqua, H. Ozbek, J. Cvacka, M. Zemlicka, K. S mejkal. Bioassay-guided isolation of the antinociceptive compounds motiol and ß-sitosterol from Scorzonera latifolia root extract. Pharmazie 2014, 69(9): 711-4.

Arıhan O, Özbek H, Özkan AMG, “Anti-inflammatory effects of Sanguisorba minor Scop. subsp. muricata (Spach) Briq. and Cirsium libanoticum DC. subsp. lycaonicum (Boiss. & Heldr.) Davis & Parris in rat”. Eastern Journal of Medicine, 20(2): 81-85, (2015).

Özbek H, Kırmızı Nİ, Cengiz N, Erdoğan E. Hepatoprotective effects of Coriandrum sativum essential oil against acute hepatotoxicity induced by carbon tetrachloride on rats. Acta Pharm Sci, 54(1):35-40, (2016).

Özbek H, Bahadır Acikara O, Keskin I, Kirmizi NI, Ozbilgin S, Oz BE, Kurtul E, Ozrenk BC, Tekin M, Saltan G. Evaluation of hepatoprotective and antidiabetic activity of Alchemilla mollis. Biomed Pharmacother 2017, 86: 172-6.

Topuk S, Akyuva Y, Karaaslan N, Mutlu CA, Yilmaz I, Isyar M, Sirin DY, Akkaya S, Özbek H, Mahirogullari M. Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems? Curr Pharm Biotechnol. 2017 Jun 14. doi: 10.2174/1389201018666170615083455.

Oznam K, Sirin DY, Yilmaz I, Kaya YE, Isyar M, Gumustas SA, Ozbek H, Akkaya S, Kayhan A, Mahirogullari M. Iopromide- and gadopentetic acid-derived preparates used in MR arthrography may be harmful to chondrocytes. J Orthop Surg Res. 2017 Jun 26;12(1):98. doi: 10.1186/s13018-017-0600-5.

Özbek H, Yılmaz BS. Anti-inflammatory and Hypoglycemic Activities of Alpha-pinene. Acta Pharm Sci, 2017, 55(4):7-14, DOI: 10.23893/1307-2080.APS.05522

Özbek H, Acıkara ÖB, Keskin İ, Kırmızı Nİ, Yiğitbaşı T, Şakul AA, İşcan GS. Preclinical Evaluation of Scorzonera sp. Root Extracts and Major Compounds against Acute Hepatotoxicity Induced by Carbon Tetrachloride, Ind J Pharm Sci, 2017, 79(5): 715-723.

Yılmaz BS, Özbek H. Investigation of the Anti-inflammatory, Hypoglycemic Activity and Median Lethal Dose (LD50) Level of Limonene in Mice and Rats, Acta Pharm Sci, 2018, 56(1): 85-94. DOI: 10.23893/1307-2080.APS.05606

Özbilgin S, Özbek H, Kırmızı NI, Ergene Öz B*, Kurtul E, Özrenk BC, Saltan İşcan G, Bahadır Acıkara Ö, Evaluation of the Antidiabetic Activity of Alchemilla persica Rothm. in Mice with Diabetes Induced by Alloxan, Turk J Pharm Sci 2019;16(3):261-264. DOI: 10.4274/tjps.galenos.2018.65487 (Ağustos 2018).

Gidiş V, Özbek H. Comparative Analysis Of Methods Concerning The Qanun and Some Stringed Instruments, ASOS Journal (The Journal Of Academic Social Science), Aralık 2018, yıl 6, 83: 216-26. dx.doi.org/10.16992/ASOS.14459 (15 Aralık 2018).

Caliskan T, Sirin DY, Karaarslan N, Yilmaz I, Ozbek H, Akyuva Y, Kaplan N, Kaya Y, Simsek A, Yildirim Guzelant A, Ates O, Effects of etanercept, a tumor necrosis factor receptor fusion protein, on primary cell cultures prepared from intact human intervertebral disc tissue, Experimental and Therapeutic Medicine 2019: 18: 69-76.

Akgun F, Sirin D, Yilmaz I, Karaarslan N, Ozbek H, Simsek A, Kaya Y, Kaplan N, Akyuva Y, Caliskan T, Ates O, Investigation of the effect of dipyrone on cells isolated from intervertebral disc tissue, Experimental and Therapeutic Medicine 2019: 18: 216-224. DOI: 10.3892/etm.2019.7576

Hacioglu Kasim FB, Dogan M, Ozbek H, Yilmaz I, Karaarslan N, A Study of Medical and Surgical Treatment of Patients with Brucella Spondylodiscitis, Merit Research Journal of Medicine and Medical Sciences, 2019, 7(5): 171-177. DOI: 10.5281/zenodo.2838819 (May 2019).

Özbek H, Gidiş V, Harmancı İlhan AB, Nîm Sofyân ve Semâî Düzüm mü? Usûl mü? Jia Journal, 2019, 2(2): 87-118. http://dx.doi.org/10.29228/jiajournal.23387 (Haziran 2019).




Yazılan ulusal veya uluslararası kitaplar veya kitaplarda bölümler (Books/Chapters)

Sleep and Sleep Disorders: a Neuropsychopharmacological Approach (vol.1 & II). Editor: Lader, Malcolm, Daniel P, Cardinali SR, Pandi-Perumal. In: Drug Effects on Dreaming. Chapter Editors: Ağargün M.Y., Özbek H. September, 2004, ISBN: 1-58706-254-2.

Recent Progress in Medicinal Plants:“The antiinflammatory activity and median lethal dose of the Foeniculum vulgare Mill. (etheric oil)”, Özbek H. and Yılmaz O, 12, 385-391 (2006).

Recent Progress in Medicinal Plants: “Are Nigella sativa and Urtica dioica Fixed Oils Effective On Carbon Tetrachloride-Induced Liver Injury Model In Rats?”, Özbek H, Öztürk M, Erdoğan E, Kösem M, 19:127-136 (2007).

Recent Progress in Medicinal Plants: “Investigation of median lethal dose (LD50) and hypoglycemic effect of Thymus fallax F. leaves essential oil”, Özbek H, Öztürk M, Özgökçe F, 23, Chapter 18, pp: 255-261 (2008).

SKS ve İlaç Güvenliği, Editörler: İrfan Şencan, Hanefi Özbek. Sağlıkta Kalite ve Akreditasyon Daire Başkanlığı, Ankara (2012), ISBN: 978-975-590-434-4.

Klinik Farmakolojinin Esasları ve Temel Düzenlemeler. 5. Baskı, Editör: S. Oğuz Kayaalp, Bölüm Editörleri: S. Oğuz Kayaalp, Mehmet Melli, Hanefi Özbek. Pelikan Yayıncılık, Ocak 2013, Ankara, ISBN: 605527036-6.

Sağlık Sorunları ve Hastalıkların Yönetimi-Cilt 1, Bölüm: Kardiyovasküler Sistemle İlgili Sorunların Yönetimi, TC Sağlık Bakanlığı, Bölüm Yazarı, Türkiye Halk Sağlığı Kurumu, Anıl Matbaacılık Ltd. Şti., Ankara-2016. ISBN: 978-975-590-615-7.

Sağlıkta Kalite Standartları Hastane, Sağlık Bakanlığı, Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite ve Akreditasyon Daire Başkanlığı, Pozitif Matbaa, Ankara-Mart 2016. ISBN: 978-975-590-558-7.

Sağlıkta Kalite Standartları Diyaliz, Sağlık Bakanlığı, Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite ve Akreditasyon Daire Başkanlığı, Anıl Reklam Matbaa Ltd, Şti, Ankara-Eylül 2016. ISBN: 978-975-590-630-0.

Sağlıkta Kalite Standartları ADSH (Ağız ve Diş Sağlığı Hizmetleri), Sağlık Bakanlığı, Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite ve Akreditasyon Daire Başkanlığı, Anıl Reklam Matbaa Ltd, Şti, Ankara-Eylül 2016. ISBN: 978-975-590-589-1

Numan Karaarslan, İbrahim Yılmaz, Duygu Yaşar Şirin, Hanefi Özbek, Özkan Ateş, Dejeneratif Kaskaddan Moleküler Tedaviye İntervertebral Disk Rejenerasyonu, Editötler: Duuygu Yaşar Şirin, Numan Karaarslan, İbrahim Yılmaz, Necati Kaplan, Bölüm 9: Kliniklerde sıkça uygulanan ilaçların intervertebral disk dejenerasyon veya rejenerasyonuna etkisinin değerlendirilmesi, Sage Yayıncılık, Ankara-Ağustos 2019.

Özbek H, Geleneksel ve Tamamlayıcı Tıp Uygulamalarının Klinik Deneylerle Kanıtlanması Mümkün mü? Tokaç M, editör. Geleneksel ve Tamamlayıcı Tıp Uygulamalarında Etik ve Hukuki Sorunlar. 1. Baskı. Ankara: Türkiye Klinikleri; 2019. p.41-4. Online ISBN: 978-605-034-017-4 (Yayımlanma tarihi: 15.10.2019).





B İ Y O İ S T A T İ S T İ K


Makale:

Özbek H, Keskin S. Standart sapma mı yoksa standart hata mı? Van Tıp Dergisi 2007, 14(2): 64-67.


Kitap:

Osman Hayran & Hanefi Özbek. Sağlık Bilimlerinde Araştırma ve İstatistik Yöntemler, (SPSS Uygulama örnekleri ile genişletilmiş 2. Baskı), Nobel Tıp Kitabevi, İstanbul-Mart 2017. ISBN: 978-605-335-297-6.




M Ü Z İ K


Makaleler:

Özbek H, “Dede Efendi üzerine”, Seyir, 1: 24-25, 1997.

Özbek H, “Türk Mûsıkîsi Nazariyâtı Üzerine Eleştirel Bir Yaklaşım”, Seyir, 2: 15-16, 1997.

Özbek H, “Mûsıkîmiz ve Sesleri”, Seyir, 3: 50, 1997.

Özbek H, “Batı Müziği Ses Sistemi”, Seyir, 4: 38-40, 1998.

Özbek H, “Türk Müziği Ses Sistemi”, Seyir, 7: 37-38, 1999.

Özbek H, “Türk Müziği Üzerine”, Seyir, 11-12: 77-78, 2000.

Özbek H, "Müzik üzerine bir söyleşi", 112 ACİL, Sayı 3, s: 56-59, 2009.

Özbek H, "Müzikle Terapi 'Müzikoterapi'", Sağlık ve İnsan, 2012, 7: 58-61.

Özbek H, "Arel-Ezgi Ses Sistemi Üzerine Bir Eleştiri", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2014, 32: 96-101.

Özbek H, "Türk Müziği ve Terapideki Yeri: Tarihsel Perspektif", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2014, 33: 100-101.

Özbek H, "Türk Müziği ve Terapideki Yeri: Bilimsel perspektif", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2015, 34: 100-103.

Özbek H, "Şarkılarda Ölüm", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2015, 36: 62-63.

Özbek H, "Geleneksel ve Tamamlayıcı Tıp Mevzuatı", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2016, 38: 82-85.

Özbek H. "Göç ve Müzik", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2016, 40: 52-55.

Özbek H. "Değerler Eğitiminde Musikinin Yeri", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2016, 41: 26-27.



Kitap:

Türk Müziğinde Ana Dizi, Hanefi Özbek, Pan Yayıncılık, İstanbul-2014, ISBN: 978-605-4518-70-8.

Türk Müziği Usûlleriyle Ritmik Okuma, Hanefi Özbek, 1. Baskı, Dahi Yayıncılık-İstanbul-Ağustos 2017. ISBN: 978-605-9092-82-1.




Ulusal veya Uluslararası Kongre/Sempozyumlara Katılım ve Sunulan Bildiriler:


Gazi Üniversitesi Gazi Eğitim Fakültesi Müzik Eğitimi Bölümü ve Sevda-Cenap And Müzik Vakfı işbirliğiyle “Türkiye’de Eğitim Fakülteleri Müzik Eğitimi Bölümleri ve Müzik Öğretmenliği Eğitimi Toplantısı”,01 Kasım 1994.

16-20 Nisan 2014, 6. Uluslararası Psikofarmakoloji Kongresi ve Çocuk ve Ergen Psikofarmakolojisi Sempozyumu, Antalya-Türkiye, Türk Sanat Musikisi ve Tedavideki Yeri.

17-18 Kasım 2014, Türk Müziği Ana Dizisi İçin Bir Öneri, İzmir II. Ulusal Müzik Sempozyumu, Bornova-İzmir.

Özbek H. Acıkara ÖB, Öz BE, Özbilgin S, Kırmızı Nİ, Özrenk C, Tekin M, Saltan G. Onobrychis türlerinin farelerde alloksan ile oluşturulmuş diyabet modelinde antidiyabetik etkilerinin araştırılması, 24. Ulusal Farmakoloji Kongresi, 17-20 Ekim 2017, Prof. Dr. Osman Turan Kültür ve Kongre Merkezi, KTÜ, Trabzon, P095.

Numan Karaarslan, İbrahim Yılmaz, Hanefi Özbek, Duygu Yaşar Şirin, Necati Kaplan, Tezcan Çalışkan, Çiğdem Özdemir, Yener Akyuva, Özkan Ateş, Diskografide sıklıkla tercih edilen radyo-kontrast farmasötikleri ile intakt intervertebral disk dokusu hücrelerine zarar mı veriyoruz? Spinal Cerrahide Komplikasyonlar Sempozyumu, 26-29 Eylül 2018, Titanic Deluxe Hotel-Bodrum, Sözlü Bildiri-S2 (Birincilik ödülü).

Numan Karaarslan, İbrahim Yılmaz, Duygu Yaşar Şirin, Hanefi Özbek, Özkan Ateş, Disk Dokusu İlaç Araştırmalarında, Anabolik/Katabolik Reaksiyonlarda Rol Alan Gen İfadelerinin Önemi, Sinir Sistemi Cerrahisi Derneği, 14. Sinir Sistemi Cerrahisi Kongresi, 08-11 Kasım 2018, İ.T.Ü. Vakfı Maçka Sosyal Tesisleri Şişli, İstanbul, Sözlü Bildiri (Üçüncülük ödülü).



Konferanslar/Söyleşiler:


YYÜ Felsefe Topluluğu söyleşi programı: "Bestekâr Hacı Sâdullah Ağa", 11 Nisan 2003, Van.

Eğitimde Bilim Danışmanlığı Bölge Çalıştayı, "Türk Mûsıkîsi Tarihi ve Kullanılan Enstrümanlar", 18-28 Haziran 2007, Van.

Eğitimde Bilim Danışmanlığı Bölge Çalıştayı, "Ûdî Bestekâr Yusuf Nalkesen", 07.12.2007, Van.

Bilgi Derneği, "Türk Mûsıkîsinin Teorik Temelleri", 13.01.2008, Van.

İstanbul Medipol Üniversitesi, "Türk Musikisi" başlıklı konuşma, 27 Aralık 2012, İstanbul.

Konya Necmettin Erbakan Üniversitesi’nin 2013-2014 akademik döneminin açılışı toplantısı, “Açılış Dersi (Eğitim, Müzik ve Sağlık)”, 23 Ekim 2013, Konya.

Mevlana Üniversitesi Tıp Fakültesi, 13.03.2014, “Biraz da Müzik” konulu sunu ve tambur dinletisi, Konya.

İstanbul Medipol Üniversitesi, Kavacık Kampüsü, 13 Şubat 2014, "Türk Musikisi’nde Usûller" konulu konuşma, İstanbul.

Özbek H, Korkut L, Çakkal Ö, "Orhan Gencebay’la Röportaj", SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2013-2014, 29: 46-57.

"Türk Müziği Ana Dizisi İçin Bir Öneri", Konferans, Uluslar Arası Müzik ve Medya Sempozyumu, 21-23 Mayıs 2014, Yıldız Teknik Üniversitesi, Beşiktaş-İstanbul.

Şizofreni İle Birlikte Yaşamak İçin Elimi Tutar mısın Sempozyumu, çağrılı konuşma: “Psikiyatrik Hastalıkların Tedavisinde Müzikterapi”, 6 Aralık 2014, Cemal Reşit Rey Konser Salonu-İstanbul.

Uluslararası Sağlık ve Sanat Sempozyumu, Konferans: "Geleneksel, Tamamlayıcı ve Alternatif Tıp Uygulamaları Mevzuatı ve Müzikterapi", 21-22 Mayıs 2015, İstanbul Medipol Üniversitesi Kavacık Yerleşkesi, İstanbul.

"Türk Müziği ve Müzik Terapide Kullanım İlkeleri", Bilişsel Rehabilitasyonda Yeni Yaklaşımlar, 2-3 Nisan 2017, İstanbul Medipol Üniversitesi, Kavacık-İstanbul,

Özbek H. Türküler ve Yaşlılık, SD (Sağlık Düşüncesi ve Tıp Kültürü Dergisi), 2017, 44: 54-55.




Radyo-Televizyon Programları:


Can Veren Pervaneler, TRT-2, 2009.

TRT Okul, Medyada Sağlık, "Çocuklarda antibiyotik kullanımı, Selçuklu ve Osmanlı’da müzikle tedavi", 01.01.2013.

TRT 1 Sözün Bitmediği Yer, "Türk Müziği Üzerine Celil Güngör’le Söyleşi", Haziran 2014.

TRT 1 Nağmede Şifa, "Geleneksel Ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği ve Müzikterapi üzerine söyleşi", Aralık 2014.

TRT TSR (Türkiye’nin Sesi Radyosu) Şifaya Yolculuk, 2015.

TRT 1 Nağmede Şifa, "Müzikterapi", Mart 2015.

Beyaz TV, Ana Haber Bülteni, Müzikterapi Uygulaması, Şubat 2016.

AKRA FM, Tamamlayıcı Tıp, Müzikle Tedavi, Kasım 2017.

text
Adı Soyadı Prof.Dr. Ertuğrul KILIÇ
E-Posta ekilic@medipol.edu.tr
Detay Öz Geçmiş
Medya

Daha Önce Görev Yaptığı Yerler

Araştırma Alanları

Beyin Felci; Nörobiyoloji

Seçili Yayınları / Tüm Yayınları

1. Elibol-Can B, Kilic E, Yuruker S, Jakubowska-Dogru E. Investigation into the effects of prenatal alcohol exposure on postnatal spine development andexpression of synaptophysin and PSD95 in rat hippocampus. Int J Dev Neurosci. 2014;33:106-14. doi: 10.1016/j.ijdevneu.2013.12.003. Epub 2013 Dec 21.

2. Elibol-Can B, Dursun I, Telkes I, Kilic E, Canan S, Jakubowska-Dogru E. Examination of Age- dependent effects of fetal ethanol exposure on behavior, hippocampal cellcounts, and doublecortin immunoreactivity in rats. Dev Neurobiol. 2013 Oct 29. doi: 10.1002/dneu.22143. [Epub ahead of print]

3. Karadeli HH, Aktekin B, Yilmaz B, Kilic E, Uzar E, Aci A, Bingol CA. Effects of melatonin on behavioral changes of neonatal rats in a model of cortical dysplasia. Eur Rev Med Pharmacol Sci. 2013 ;17(15):2080-4

4. Sehirli AO, Koyun D, Tetik S, Ozsavcı D, Yiğiner O, Cetinel S, Tok OE, Kaya Z, Akkiprik M, Kilic E, Sener G. Melatonin protects against ischemic heart failure in rats. J Pineal Res. (2013) 55(2):138-48

5. Kilic U, Yilmaz B, Reiter RJ, Yüksel A, Kilic E. Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice. Neuroscience. (2013) May 1;237:268-76

6. Kilic U, Kilic E, Tuzcu Z, Tuzcu M, Ozercan IH, Yilmaz O, Sahin F, Sahin K. Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway. Nutr Metab (Lond). (2013) 12;10(1):7

7. Kilic U, Yilmaz B, Ugur M, Yüksel A, Reiter RJ, Hermann DM, Kilic E. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia (2012) Journal of Pineal Research, 52: 228-35. (I.F.: 5.85)

8. Kelestemur S, Kilic E, Uslu U, Cumbul A, Ugur M, Akman S, Culha M. Wound Healing Properties of Modified Silver Nanoparticles and their Distribution in Mouse Organs after Topical Application. (2012) Nano Biomedicine and Engineering, 4: 170-176.

9. Herz J, Reitmeir R, Hagen SI, Reinboth BS, Guo Z, Zechariah A, Elali A, Doeppner TR, Bacigaluppi M, Pluchino S, Kilic U, Kilic E, Hermann DM.Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. (2012) Neurobiology of Diseases, 45:1077-85 (I.F.: 4.9)

10. Reitmeir R, Kilic E, Reinboth BS, Guo Z, ElAli A, Zechariah A, Kilic U, Hermann DM. Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brain.. (2012) Acta Neuropathologica. 123: 273-84 (I.F.: 7.5)

11. Mete F, Kilic E, Somay A, Yilmaz B. Effects of heat stress on endocrine functions & behaviour in the pre-pubertal rat. Indian J Med Res. 2012;135:233-9.

12. Reitmeir R., Kilic E, Kilic U, Bacigaluppi, M, ElAli A, Salani G, Pluchino S, Gassmann M, Hermann DM. Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodeling and contralesional pyramidal tract plasticity. (2011) Brain, 134:84-99 (I.F.: 9.603)

13. Kilic E, Elali A, Kilic U, Guo Z, Ugur M, Uslu U, Bassetti CL, Hermann DM. Role of Nogo-A in neuronal survival in the reperfused ischemic brain (2010) Journal of Cerebral Blood Flow and Metabolism, 30 (5), pp. 969-984. (I.F.: 5.741)

14. Tug, N., Kilic, U., Karateke, A., Yilmaz, B., Ugur, M., Kilic, E. Erythropoietin receptor-like immunostaining on human spermatozoa. (2010) Reproductive BioMedicine Online 21 (5):718-720. (I.F.: 2.380)

15. Yulug B, Erkol G, Kilic E. An interesting link between microgravity and psychiatric diseases. (2010) J Neuropsychiatry Clin Neurosci. 22: 451-g.e12-451.e12. . (I.F.: 2.362)

16. Yulug B, Ozan E, Kilic E. Brain-derived neurotrophic factor polymorphism as a genetic risk for depression? A short review of the literature. (2010) J Neuropsychiatry Clin Neurosci. Winter;22(1):123d.e5-123.e6

17. Muammer R, Kilic E, Hayran O. The effect of physiotherapy treatment on saliva decrease in children with cerebral palsy. Indian Journal of Physiotherapy and Occupational Therapy—An International Journal. (2010) 4: 129-131

18. Sahin K, Akdemir F, Tuzcu M, Sahin N, Onderci M, Ozercan R, Ilhan N, Kilic E, Seren S, Kucuk O. Genistein suppresses spontaneous oviduct tumorigenesis in quail. (2009) Nutr Cancer. 2009 Nov;61(6):799-806. (I.F.: 2.360)

19. Yalvac, M.E., Rizvanov, A.A., Kilic, E., Sahin, F., Mukhamedyarov, M.A., Islamov, R.R., Palotás, A. Potential role of dental stem cells in the cellular therapy of cerebral ischemia (2009) Current Pharmaceutical Design, 15 (33), pp. 3908-3916. (I.F.: 4.399)

20. Yulug B, Kilic E. Olanzapine does not aggrevate ischemic neuronal injury by focal cerebral ischemia: A dose related restriction of the neuroprotective effect? (2009) Medicinal Chemistry, 5 (3), pp. 279-282. (I.F.: 2.362)

21. Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, Kilic E, Kilic U, Salani G, Brambilla E, West MJ, Comi G, Martino G, Hermann DM. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms (2009) Brain, 132 (8), pp. 2239-2251. (I.F.: 9.603)

22. Aydin O. Kahraman M. Kilic E. Çulha M. Surface-enhanced raman scattering of rat tissues (2009) Applied Spectroscopy, 63 (6), pp. 662-668. (I.F.: 2.062)

23. Yildirim G, Attar R, Ficicioglu C, Karateke A, Ozkan F, Kilic E, Yilmaz B, Yesildaglar N. Kombine letrozol ve melatonin tedavisinin deneysel rat endometriosis modelinde lezyon boyutları ve histopatolojik skorlar üzerine etkisi J Turkish German Gynecol Assoc. Year: 2009 Volume: 10 Issue: 4 199-204

24. Yulug B, Ozan E, Gönül AS, Kilic E. Brain-derived neurotrophic factor, stress and depression: A minireview (2009) Brain Research Bulletin, 78 (6), pp. 267-269. (I.F.: 2.281) X

25. Hermann DM, Kilic E. Therapeutic potential and possible risks of pleiotropic growth factors in ischemic stroke (2008) Stroke, 39 (11), p. e182. (I.F.: 6.499)

26. Cam E, Yulug B, Cengiz N, Poelkin E, Isik D, Bakar M, Ozan E, Kilic E. Melatonin: A suitable agent for depression associated with stroke? (2008) Journal of Neuropsychiatry and Clinical Neurosciences, 20 (4), pp. 498-500. (I.F.: 2.362)

27. Kilic E, Hermann DM, Spudich A, Kilic Ü, Rentsch KM, Vig R, Matter CM, Bassetti CL. ABCC1: A gateway for pharmacological compounds to the ischaemic brain (2008) Brain, 131 (10), pp. 2679-2689. (I.F.: 9.603)

28. Gao B, Kilic E, Baumann CR, Hermann DM, Bassetti CL. Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia (2008) Cerebrovascular Diseases, 26 (4), pp. 413-419. (I.F.: 3.041)

29. Kilic E, Kilic U, Bacigaluppi M, Guo Z, Abdallah NB, Wolfer DP, Reiter RJ, Bassetti CL. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice (2008) Journal of Pineal Research, 45 (2), pp. 142-148. (I.F.: 5.056)

30. Kilic U, Kilic E, Matter CM, Bassetti CL, Hermann DM. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration (2008) Neurobiology of Disease, 31 (1), pp. 33-40. (I.F.: 4.852)

31. Bacigaluppi M, Pluchino S, Martino G, Kilic E, Hermann DM. Neural stem/precursor cells for the treatment of ischemic stroke (2008) Journal of the Neurological Sciences, 265 (1-2), pp. 73-77. (I.F.: 2.359)

32. Hédou GF, Koshibu K, Farinelli M, Kilic E, Gee CE, Kilic U, Baumgärtel K, Mansuy IM. Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain (2008) Journal of Neuroscience, 28 (1), pp. 154-162. (I.F.: 7.452)

33. Kilic E, Hermann DM, Wippel A, Kilic Ü, Vogel P, Kim M, van der Putten H, Böttiger BW. Poxvirus-derived cytokine response modifier A (CrmA) does not protect against focal cerebral ischemia in mice (2007) Brain Research, 1185 (1), pp. 293-300. (I.F.: 2.494)

34. Yulug B, Cam E, Yildiz A, Kilic E. Buprenorphine does not aggrevate ischemic neuronal injury in experimental focal cerebral ischemia (2007) Journal of Neuropsychiatry and Clinical Neurosciences, 19 (3), pp. 331-334. (I.F.: 2.362)

35. Kilic Ü, Hermann DM, Kilic E, Järve, A, Guo, Z, Spudich, A, Bieber, K, Marti HH. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways (2006) Journal of Neuroscience, 26 (48), pp. 12439-12446. (I.F.: 7.452)

36. Hermann DM, Kilic E, Spudich A, Krämer SD, Wunderli-Allenspach H, Bassetti CL. Role of drug efflux carriers in the healthy and diseased brain (2006) Annals of Neurology, 60 (5), pp. 489-498. (I.F.: 9.935)

37. Baumann CR, Kilic E, Petit B, Werth E, Hermann DM, Tafti M, Bassetti CL. Sleep EEG changes after middle cerebral artery infarcts in mice: Different effects of striatal and cortical lesions (2006) Sleep, 29 (10), pp. 1339-1344. (I.F.: 4.475)

38. Kilic E, Kilic Ü, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia (2006) FASEB Journal, 20 (8), pp. E307-E314. (I.F.: 7.049)

39. Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. (2006) The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 20 (8), pp. 1185-1187. (I.F.: 7.049)

40. Yulug B, Yildiz A, Güzel O, Kilic E, Schäbitz WR, Kilic E. Risperidone attenuates brain damage after focal cerebral ischemia in vivo (2006) Brain Research Bulletin, 69 (6), pp. 656-659. (I.F.:2.281)

41. Spudich A, Kilic E, Xing H, Kilic Ü, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia (2006) Nature Neuroscience, 9 (4), pp. 487-488. (I.F.: 14.164)

42. Kilic E, Kilic U, Hermann DM. TAT fusion proteins against ischemic stroke: Current status and future perspectives (2006) Frontiers in Bioscience, 11 (2), pp. 1716-1721. (I.F.: 3.308)

43. Kilic E, Kilic Ü, Soliz J, Bassetti CL, Gassmaim M, Hermann DM. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways (2005) FASEB Journal, 19 (14), pp. 2026-2028. (I.F.: 7.049)

44. Kilic, E, Kilic Ü, Hermann DM. TAT-GDNF in neurodegeneration and ischemic stroke (2005) CNS Drug Reviews, 11 (4), pp. 369-378. (I.F.: 4.432)

45. Kilic E, Kilic Ü, Bähr M, Hermann DM. Tissue plasminogen activator-induced ischemic injury is reversed by NMDA antagonist MK-801 in vivo (2005) Neurodegenerative Diseases, 2 (2), pp. 49-55. (I.F.: 2.989)

46. Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, Hermann DM. Aggravation of ischemic brain injury by prion protein deficiency: Role of ERK-1/-2 and STAT-1 (2005) Neurobiology of Disease, 20 (2), pp. 442-449. (I.F.: 4.852)

47. Kilic E, Kilic Ü, Reiter RJ, Bassetti CL, Hermann DM. Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: Role of iNOS and Akt (2005) Journal of Pineal Research, 39 (2), pp. 151-155. (I.F.: 5.056)

48. Kilic Ü, Bassetti CL, Kilic E, Xing H, Wang Z, Hermann DM. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2 (2005) Neuroscience, 134 (3), pp. 901-906. (I.F.: 3.556)

49. Grimm C, Hermann DM, Bogdanova A, Hotop S, Kilic Ü, Wenzel A, Kilic E, Gassmann M. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration (2005) Seminars in Cell and Developmental Biology, 16 (4-5), pp. 531-538. (I.F.: 4.528)

50. Reiter RJ, Tan DX, Leon J, Kilic Ü, Kilic E. When melatonin gets on your nerves: Its beneficial actions in experimental models of stroke (2005) Experimental Biology and Medicine, 230 (2), pp. 104-117. (I.F.: 2.202)

51. Kilic Ü, Kilic E, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2 (2005) FASEB Journal, 19 (2), pp. 249-251. (I.F.: 7.049)

52. Kilic E, Kilic Ü, Matter CM, Lüscher TF, Bassetti CL, Hermann DM. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase (2005) Stroke, 36 (2), pp. 332-336. (I.F.: 6.499)

53. Kilic Ü, Kilic E, Reiter RJ, Bassetti CL, Hermann DM. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice (2005) Journal of Pineal Research, 38 (1), pp. 67-71. (I.F.: 5.056)

54. Wang Y, Kilic E, Kilic Ü, Weber B, Bassetti CL, Marti HH, Hermann DM. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena (2005) Brain, 128 (1), pp. 52-63. (I.F.: 9.603)

55. Kilic E, Kilic Ü, Reiter RJ, Bassetti CL, Hermann DM. Prophylactic use of melatonin protects against focal cerebral ischemia in mice: Role of endothelin converting enzyme-1 (2004) Journal of Pineal Research, 37 (4), pp. 247-251. (I.F.: 5.056)

56. Kilic E, Weishaupt JH, Kilic Ü, Rohde G, Yulug B, Peters K, Hermann DM, Bähr M. The superoxide dismutase1 (SOD1) G93A mutation does not promote neuronal injury after focal brain ischemia and optic nerve transection in mice (2004) Neuroscience, 128 (2), pp. 359-364. (I.F.: 3.556)

57. Reiter RJ, Kilic Ü, Tan DX, Gitto E, Sainz RM, Mayo JC, Leon J, Kilic E. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage (2004) Polish Journal of Pharmacology, 56 (2), pp. 159-170. (I.F.: 2.167, The Pharmacological Reports)

58. Kilic Ü, Kilic E, Lingor P, Yulug B, Bähr M. Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro (2004) Acta Neuropathologica, 108 (1), pp. 65-68. (I.F.: 5.310)

59. Kilic Ü, Kilic E, Dietz GPH, Bähr M. The TAT protein transduction domain enhances the neuroprotective effect of glial-cell-line-derived neurotrophic factor after optic nerve transection (2004) Neurodegenerative Diseases, 1 (1), pp. 44-49. (I.F.: 2.989)

60. Kilic E, Kilic Ü, Yulug B, Hermann DM, Reiter RJ. Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator (2004) Journal of Pineal Research, 36 (3), pp. 171-176. (I.F.: 5.056)

61. Kilic E, Kilic Ü, Bassetti CL, Hermann DM. Intravenously administered recombinant tissue-plasminogen activator attenuates neuronal injury after mild focal cerebral ischemia in mice (2004) NeuroReport, 15 (4), pp. 687-689. (I.F.: 1.904)

62. Yulug B, Kilic U, Kilic E, Bähr M. Rifampicin attenuates brain damage in focal ischemia (2004) Brain Research, 996 (1), pp. 76-80. (I.F.: 2.494)

63. Kilic Ü, Kilic E, Dietz GPH, Bähr M. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice (2003) Stroke, 34 (5), pp. 1304-1310. (I.F.: 6.499)

64. Kügler S, Kilic E, Bähr M. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area (2003) Gene Therapy, 10 (4), pp. 337-347. (I.F.: 4.492)

65. Kilic E, Hermann DM, Kügler S, Kilic Ü, Holzmüller H, Schmeer C, Bähr M. Adenovirus-mediated Bcl-XL expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice (2002) Neurobiology of Disease, 11 (2), pp. 275-284. (I.F.: 4.852)

66. Kilic E, Dietz GPH, Hermann DM, Bähr M. Intravenous TAT-Bcl-XL is protective after middle cerebral artery occlusion in mice (2002) Annals of Neurology, 52 (5), pp. 617-622. (I.F.: 9.935)

67. Dietz GPH, Kilic E, Bähr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction (2002) Molecular and Cellular Neuroscience, 21(1), pp. 29-37. (I.F.: 3.934)

68. Kilic E, Hermann DM, Isenmann S, Bähr M. Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice (2002) Journal of Pineal Research, 32 (2), pp. 106-111. (I.F.: 5.056)

69. Hermann DM, Kilic E, Kügler S, Isenmann S, Bähr M. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats (2001) Neurobiology of Disease, 8 (6), pp. 964-973. (I.F.: 4.852)

70. Kilic E, Bähr M, Hermann DM. Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: Role of hemodynamic alterations (2001) Stroke, 32 (11), pp. 2641-2647. (I.F.: 6.499)

71. Dietz GPH, Kilic E, Bähr M, Isenmann S. Bcl-2 is not required in retinal ganglion cells surviving optic nerve axotomy (2001) NeuroReport, 12 (15), pp. 3353-3356. (I.F.: 1.904)

72. Hermann DM, Kilic E, Kügler S, Isenmann S, Bähr M. Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice (2001) Neurobiology of Disease, 8 (4), pp. 655-666. (I.F.: 4.852)

73. Knöll B, Isenmann S, Kilic E, Walkenhorst J, Engel S, Wehinger J, Bähr M, Drescher U. Graded expression patterns of ephrin-As in the superior colliculus after lesion of the adult mouse optic nerve (2001) Mechanisms of Development, 106 (1-2), pp. 119-127. (I.F.: 2.534)

74. Hermann DM, Kilic E, Hata R, Hossmann K-A, Mies G. Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice (2001) Neuroscience, 104 (4), pp. 947-955. (I.F.: 3.556)

75. Sönmez AS, Birincio?lu M, Aydin A, Kiliç E, Şahin N. Effects of misoprostol on the endometrium of ovariectomized rats (2000) Turkish Journal of Medical Sciences, 30(2),pp. 115-118.

76. Kilic E, Hermann DM, Hossmann KA. Recombinant tissue-plasminogen adivator-induced thrombolysis after cerebral thromboembolism in mice (2000) Acta Neuropathologica, 99 (3), pp. 219-222. (I.F.: 5.310)

77. Kilic E, Özdemir YG, Bolay H, Keleştimur H, Dalkara T. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia (1999) Journal of Cerebral Blood Flow and Metabolism, 19 (5), pp. 511-516. (I.F.: 5.741)

78. Kilic E, Hermann DM, Hossmann KA. Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice
(1999) NeuroReport, 10 (1), pp. 107-111. (I.F.: 1.904)

79. Kilic E, Hermann DM, Hossmann KA. A reproducible model of thromboembolic stroke in mice (1998) NeuroReport, 9 (13), pp. 2967-2970. (I.F.: 1.904)








text
Adı Soyadı Dr.Öğr.Üye. Ayşe Arzu ŞAKUL
E-Posta aasakul@medipol.edu.tr
Detay Öz Geçmiş
Medya

Ondokuzmayıs Üniversitesi 1994 Hacettepe Üniversitesi Tıp Fakültesi & Gazi Üniversitesi Tıp Fakültesi

Daha Önce Görev Yaptığı Yerler

Sağlık Bakanlığı-Acil Sağlık Hizmetleri Genel Müdürlüğü- Afet ve Acil Durum Daire Başkanlığı- Ulusal Zehir Merkezi Koordinatörü

Araştırma Alanları

Diabetes Mellitus, oksidatif ve nitrozatif stres, senescence ve rejenerasyon, bağımlılık farmakolojisi, klinik toksikoloji, klinik farmakoloji, nörofarmakoloji

Seçili Yayınları / Tüm Yayınları

Kurum Dışı Görevlendirme